Blog

Posted onbyNorman "Ned" Sharpless, M.D., National Cancer Institute

New Cancer Drug

NCI Support for Basic Science Paves Way for Kidney Cancer Drug Belzutifan

Theres exciting news for people with von Hippel-Lindau (VHL) disease, a rare genetic disorder that can lead to cancerous and non-cancerous tumors in multiple organs, including the brain, spinal cord, kidney, and pancreas. In August 2021, the FDA approved belzutifan (Welireg), a new drug that has been shown in a...

Read More . . .


This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612 GovDelivery logo